Abstract
Background: Home dialysis patients may be at an increased risk of adverse events after transitional states. The home dialysis virtual ward (HDVW) trial was conducted in Canadian dialysis centers and aimed to evaluate potential care gaps and patient satisfaction during the HDVW. Methods: The HDVW was a multicenter single-arm trial including peritoneal dialysis and home hemodialysis patients after 4 different events (hospital discharge, medical procedure, antibiotics, completion of training). Telephone-led interviews using a standardized assessment tool were performed over a 2-week period to assess a patient's care and adjust treatment as required. Upon completion, patients were surveyed to evaluate their perceived impact on domains of care using a rating scale; 1 not satisfied to 10 completely satisfied. Results: The HDVW trial included 193 patients with a median number of potential care gaps/interventions of 1 (0-2) per patient. Patients admitted to the HDVW after hospital discharge were at a higher risk of potential gaps in care (OR 2.16, 95% CI 1.29-3.62), while longer dialysis vintage was -associated with a lower number of gaps/interventions (OR 0.97 per year, 95% CI 0.95-0.98). A total of 105/193 (54%) patients completed satisfaction surveys. Patients were highly satisfied with the HDVW (median rating scale score 8, IQR 2) and felt it had a positive impact (rating scale score ≥7) on their overall health, understanding of treatment and access to a nephrologist. Conclusion: The HDVW was effective at identifying several potential care gaps, and patients were satisfied across several domains of care. This intervention may be valuable in supporting home dialysis patients during care transitions.
Original language | English |
---|---|
Pages (from-to) | 392-400 |
Number of pages | 9 |
Journal | American Journal of Nephrology |
Volume | 50 |
Issue number | 5 |
DOIs | |
Publication status | Published - Nov 1 2019 |
Bibliographical note
Funding Information:This study was funded by a Baxter High Dose HD Clinical Evidence Council Grant.
Funding Information:
A.-C.N.-F.: none relevant to this study. Has a scholarship from Les Fonds de la Recherche du Québec en Santé. J.M.B., C.T.C., M.A.C., S.N.F., R.P.P., and N.A.S.: none to declare. M.J.O.: Research support from Baxter Healthcare and Medtronic. Coinvent-er of DMAR systems. Consultant to Pursuit Vascular. J.P.: none relevant to this study. Has received consulting fees from Baxter Healthcare and DaVita and speaker honoraria from Baxter Inter-
Publisher Copyright:
© 2019 S. Karger AG, Basel. Copyright: All rights reserved.
ASJC Scopus Subject Areas
- Nephrology